Malaria is a prevalent disease, specifically during monsoons. If not treated for a specific duration, it might cause death. The disease is spread through the bite of the mosquito, which is already infected by tiny parasites. When such mosquito bites, it injects the parasite causing disease into the bloodstream.

The incidences of malaria are common in tropical areas with hot and humid weather. Around 241 million malaria cases were reported worldwide, in 2020, including 627,000 deaths due to it. The majority of cases were reported from South Asia and Africa.

How is malaria caused?
If a mosquito bites a person with malaria, the mosquito gets the infection, and thereafter if it bites any other person, it transfers the malaria parasite into the bloodstream of that person, making him or her also infected. These parasites multiply in the bloodstream. Humans can be infected by five types of malaria parasites.

Pregnant women can pass malaria to their children, before or during the birth, in most rare cases.

It is least likely to happen but has the possibility to pass the disease through organ donations, blood transfusions, and hypodermic needles.

For Getting Sample Pages of This Report:-

https://www.psmarketresearch.com/market-analysis/malaria-treatment-market/report-sample

Malaria Treatment
Early treatment of malaria is crucial to get early relief from its adverse effects on health. Usually, the doctor prescribes medicines to kill the malaria parasite. Several parasites may show resistance to malaria drugs.

Several drugs are taken by combining them with other drugs. It depends upon the parasite what type of medication is needed and for how long should be taken.

Major Antimalarial Drugs
Artemisinin drugs: They provide the best treatment for plasmodium falciparum malaria with artemisinin combination therapy.
Atovaquone
Chloroquine-Several parasites may show resistance to it.
Doxycycline

The major pharmaceutical companies offering malarial treatment are Sun Pharmaceutical Industries Limited, Novartis AG, Mylan N.V., and Teva Pharmaceuticals Industries Ltd.

The growing prevalence of malaria boosts the demand for its treatment, more specifically in tropic regions with hot and humid weather.